Effects of Irbesartan on Uric Acid Metabolism in Patients with Treated Essential Hypertension-Reference-Cited by-同舟云学术

Effects of Irbesartan on Uric Acid Metabolism in Patients with Treated Essential Hypertension

Published:2018-03-31 Issue:1 Volume:2 Page:11-19
ISSN:2432-4477
Container-title:Vascular Failure
language:en
Short-container-title:Vasc Fail

Author:

Miyazaki Satoshi¹,Sakuragi Tetsushi²,Hamada Toshihiro³,Sugihara Shinobu⁴,Park Daeho³,Inoue Kazuoki³,Mizuta Einosuke⁵,Yamamoto Yasutaka⁶,Ohtahara Akira⁵,Kuwabara Masanari⁷,Sakaguchi Hiromi⁸,Nozaka Yoshihito⁹,Kishida Senzou¹⁰,Ogino Kazuhide¹¹,Kato Masahiko⁴,Taniguchi Shin-ichi³,Yoshida Akio¹²,Ninomiya Haruaki¹³,Yamamoto Kazuhiro⁴,Hisatome Ichiro¹²

Affiliation:

1. Division of Cardiology, Fujii Masao Memorial Hospital

2. Center for Promoting Next-Generation Highly Advanced Medicine, Tottori University Hospital

3. Department of Community-Based Family Medicine, Tottori University, Faculty of Medicine

4. Division of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University

5. Department of Cardiology, Sanin Rosai Hospital

6. Department of Cardiovascular Medicine, Yasutaka Yamamoto Cardiology Clinic

7. Department of Cardiology, Toranomon Hospital

8. Department of Radiology, Faculty of Medicine, Tottori University

9. Department of Medicine, Nosaka Clinic

10. Department of Medicine, Shinsei Hospital

11. Department of Clinical Laboratory, Tottori University Hospital

12. Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University

13. Department of Biological Regulation, Tottori University Faculty of Medicine

Publisher

Japan Society for Vascular Failure

Link

https://www.jstage.jst.go.jp/article/vascfail/2/1/2_11/_pdf

Reference23 articles.

1. 1) Ohta Y, Tsuchihashi T, Arakawa K, Onaka U, Ueno M. Prevalence and lifestyle characteristics of hypertensive patients with metabolic syndrome followed at an outpatient clinic in Fukuoka, Japan. Hypertens Res 2007; 30: 1077-82.

2. 2) Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men; The Osaka Health Survey. J Hypertens 2001; 19: 1209-15.

3. 3) Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertension Res 2001; 24: 691-7.

4. 4) Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med 1966; 275: 457-64.

5. 5) Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980; 93: 817-21.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uric acid in atherosclerosis and cardiovascular diseases: innocent bystander or ruthless killer?;Exploration of Musculoskeletal Diseases;2024-06-03